US bill passed to restrict business with Chinese biotech companies
The bill was passed by US House of Representatives and now awaits approval by the US Senate and the President.
Regulation
NHS England offers MSD belzutifan for von Hippel-Lindau disease
UK bans xylazine and 21 other substances to fight drug abuse
FDA grants fast track status to Innovent’s IBI363 for melanoma
Global Calcium hit with Form 483 after Indian factory inspection
FDA grants fast track status to BeiGene’s BGB-16673 for CLL/SLL
AstraZeneca may pull plug on UK vaccine manufacturing plans
South African president calls on WHO for better mpox response
